TrialJAMA dermatology2025

Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality Improvement.

Andrew Alexis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.